This report provides exclusive insights into the COVID-19 impact on the Resorbable Vascular Scaffold Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Resorbable Vascular Scaffold Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Resorbable Vascular Scaffold Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on the resorbable vascular scaffold market provides an in-depth analysis of segments
and sub-segments in the global as well as regional resorbable vascular scaffold
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional resorbable vascular scaffold market over
the short term as well as long term. The report is a comprehensive presentation
of trends, forecast and dollar values of the global resorbable vascular scaffold
market. According to the report, the global resorbable vascular scaffold market
is projected to grow at a CAGR of 15.13% over the forecast period of 2019-2025.
Cardiovascular diseases are affecting millions of people all
over the world. Significant rise in heart-related disease can be seen in the
Asia-Pacific region in the last few years. The resorbable vascular scaffold
provides better relief to the patients suffering from various heart-related
abnormalities with less invasive procedures. A resorbable vascular scaffold is
a non-metallic, non-permanent, mesh tube structure that is used to remove or
clear cholesterol and fatty deposits in the narrowed artery. Resorbable
vascular scaffold (BVS) is similar in appearance to a stent but dissolves after
the artery starts to work with its normal way, normally within 12 to 24 months.
It is designed to restore the function of the blocked artery in the heart and
restore blood flow to the heart muscle. A rising number of heart-related
problems are increasing the demand for an advanced resorbable vascular scaffold
in the market.
Rising cardiovascular disease globally is the major driving
factor for the growth of the resorbable vascular scaffold market. According to
WHO cardiovascular disease are the number one cause of death globally, failure
of the heart mainly caused by a blockage in the arteries and insufficient blood
supply to heart muscles. Moreover changing lifestyle, increasing smoking habits
in the young generation, and unhealthy food intake habits are increasing the
rate of cardiovascular disease. Furthermore, efforts taken by the government
and non-government organizations for awareness of heart diseases all over the
globe by initiatives taken by the government and private sectors are rising the
demand for a resorbable vascular scaffold market. However, the high costs
associated with implant and treatment costs can hinder the growth of the
market. On the other hand, government funding for research and improvement in
reimbursement policies can provide better opportunities for the market.
Geographically, the resorbable vascular scaffold market is
categorized into North America, Europe, Asia-Pacific, and RoW. North America
dominates the region in the forecast period followed. According to the centers
for disease control and prevention, heart disease causes around 610,000 deaths
in the U.S. each year. Europe region is anticipated to grow with a significant
rate owing to an increase in the geriatric population, change in lifestyle,
technological advancements in the healthcare sector. Resorbable vascular
scaffold market in the Asia-Pacific region expected to grow with the healthy rate
in the forecast period, factors such as changing food habitat and rising
alcohol consumption among the younger generation are increasing the prevalence
of cardiovascular diseases such as coronary heart disease in this region.
The report on the global resorbable vascular scaffold market
covers segments such as material type, application, and end user. On the basis
of material type, the sub-markets include metal based BVS, and polymer based
BVS. On the basis of application, the sub-markets include coronary artery
stents, and peripheral artery stents. On the basis of end user, the sub-markets
include hospitals, ambulatory surgical centers, and cardiac centers.
The report provides profiles of the companies in the market
such as Abbott Laboratories, Medtronic plc, Biotronik SE & Co. KG, REVA
Medical, Inc., Boston Scientific Corporation, Biosensors International Group,
Limited, Svelte Medical Systems, Inc., Stentys SA, Kyoto Medical, Elixir
Medical Corporation, and Other Companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the resorbable
vascular scaffold market. Moreover, the study highlights current market trends
and provides forecast from 2019-2025. We also have highlighted future trends in
the market that will affect the demand during the forecast period. Moreover,
the competitive analysis given in each regional market brings an insight into
the market share of the leading players.